Allen Mooney & Barnes Investment Advisors LLC Eli Lilly & CO Transaction History

Allen Mooney & Barnes Investment Advisors LLC

$587 Billion
Q3 2024

A detailed history of Allen Mooney & Barnes Investment Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Allen Mooney & Barnes Investment Advisors LLC holds 5,121 shares of LLY stock, worth $4.63 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

5,121

Previous 5,004 2.34%

Holding current value

$4.63 Million

Previous $4.53 Billion 0.14%

% of portfolio

0.77%

Previous 0.81%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$772.14 - $960.02 $90,340 - $112,322	117 Added 2.34%	5,121 $4.54 Billion
Q2 2024 Jul 11, 2024	SELL	$724.87 - $909.04 $410,276 - $514,516	-566 Reduced 10.16%	5,004 $4.53 Billion
Q1 2024 Apr 12, 2024	SELL	$592.2 - $792.28 $283,663 - $379,502	-479 Reduced 7.92%	5,570 $4.23 Billion
Q4 2023 Jan 22, 2024	SELL	$525.19 - $619.13 $31,511 - $37,147	-60 Reduced 0.98%	6,049 $3.53 Billion
Q3 2023 Nov 21, 2023	BUY	$434.7 - $599.3 $2.66 Million - $3.66 Million	6,109 New	6,109 $3.28 Billion
Q2 2023 May 23, 2024	BUY	$350.74 - $468.98 $138,893 - $185,716	396 Added 6.93%	6,107 $2.86 Billion
Q1 2023 May 23, 2024	SELL	$310.63 - $364.82 $68,338 - $80,260	-220 Reduced 3.71%	5,711 $1.96 Billion
Q4 2022 May 23, 2024	BUY	$321.55 - $374.67 $116,079 - $135,255	361 Added 6.48%	5,931 $2.17 Billion
Q3 2022 May 23, 2024	BUY	$296.48 - $337.87 $296 - $337	1 Added 0.02%	5,929 $1.92 Billion
Q2 2022 May 23, 2024	BUY	$278.73 - $327.27 $836 - $981	3 Added 0.05%	5,928 $1.92 Billion
Q1 2022 May 23, 2024	BUY	$234.69 - $291.66 $83,314 - $103,539	355 Added 6.37%	5,925 $1.7 Billion

Others Institutions Holding LLY

# of Institutions

3,901

Shares Held

765M

Call Options Held

6.35M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $859B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allen Mooney & Barnes Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allen Mooney & Barnes Investment Advisors LLC with notifications on news.

Account

Allen Mooney & Barnes Investment Advisors LLC Eli Lilly & CO Transaction History